Bristol-Myers Squibb
BMY
$74.45
Share price
2.31%
Change (1 day)
12.48%
Change (1 year)
Categories
Earnings for Bristol-Myers Squibb (BMY)
Earnings in 2022 (TTM): $7.71 B
According to Bristol-Myers Squibb's latest financial reports the company's current earnings (TTM) are $7.71 B. In 2021 the company made an earning of $8.09 B an increase over its 2020 earnings that were of -$6.88 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Bristol-Myers Squibb from 2001 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $7.71 B | -4.77% |
| 2021 | $8.09 B | -217.86% |
| 2020 | -$6.88 B | -238.11% |
| 2019 | $4.97 B | -16.64% |
| 2018 | $5.96 B | 16.31% |
| 2017 | $5.13 B | -13.25% |
| 2016 | $5.91 B | 184.79% |
| 2015 | $2.07 B | -12.77% |
| 2014 | $2.38 B | -17.64% |
| 2013 | $2.89 B | 23.55% |
| 2012 | $2.34 B | -66.48% |
| 2011 | $6.98 B | 14.99% |
| 2010 | $6.07 B | 8.37% |
| 2009 | $5.60 B | 0.86% |
| 2008 | $5.55 B | 57.16% |
| 2007 | $3.53 B | 34.12% |
| 2006 | $2.63 B | -41.65% |
| 2005 | $4.51 B | 2.22% |
| 2004 | $4.41 B | -5.88% |
| 2003 | $4.69 B | 133.53% |
| 2002 | $2.01 B | -30.59% |
| 2001 | $2.89 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $23.03 B | 198.73% | 🇺🇸 USA |
 Novartis NVS | $23.58 B | 205.77% | 🇨🇭 Switzerland |
 Pfizer PFE | $34.92 B | 352.84% | 🇺🇸 USA |
 AbbVie ABBV | $14.78 B | 91.69% | 🇺🇸 USA |
 Eli Lilly LLY | $6.54 B | -15.07% | 🇺🇸 USA |
 Amgen AMGN | $7.72 B | 0.22% | 🇺🇸 USA |
 Sanofi SNY | $8.65 B | 12.20% | 🇫🇷 France |
 Biogen BIIB | $3.39 B | -56.00% | 🇺🇸 USA |
 Merck MRK | $17.77 B | 130.50% | 🇺🇸 USA |
 AstraZeneca AZN | $2.38 B | -69.09% | 🇬🇧 UK |